[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f6bgdu7n059k3":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":4,"approvalsBeforeLoe":23,"products":24,"patents":37,"exclusivities":38,"paragraphIv":39,"catalysts":41},"SUBUTEX","BUPRENORPHINE HYDROCHLORIDE","INDIVIOR","indivior",[20],"020732","none",2,0,[25,33],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"020732-002","002","TABLET","SUBLINGUAL","EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2002-10-08","DISCN",{"key":34,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"020732-003","003","EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",[],[],{"asOf":12,"firstFiled":12,"entries":40},[],[42,50],{"id":43,"type":44,"eventDate":45,"detectedAt":46,"product":26,"payload":47,"historical":4},2547,"ANDA_APPROVED","2025-12-10","2026-10-25T00:13:58.561Z",{"route":29,"andaNo":48,"sponsor":49,"dosageForm":28,"ingredient":16},"218473","SPECGX LLC",{"id":51,"type":44,"eventDate":52,"detectedAt":53,"product":26,"payload":54,"historical":4},2478,"2025-12-18","2026-10-25T00:13:48.030Z",{"route":29,"andaNo":55,"sponsor":56,"dosageForm":28,"ingredient":16},"219401","ASCENT PHARMS INC"]